跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tysabri Concentrate for Solution for Infusion 300mg/15ml - HSA Drug Approval Details
Approvals
/
HSA
/
Tysabri Concentrate for Solution for Infusion 300mg/15ml
Approved
STANDARD
Tysabri Concentrate for Solution for Infusion 300mg/15ml
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
6b98a7a8f0c74464
Company
Unknown
Type
Standard
Approval Details
Approval Id
6b98a7a8f0c74464
Drug Name
Tysabri Concentrate for Solution for Infusion 300mg/15ml
Active Ingredients
Natalizumab
300 mg/15mL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
6b98a7a8f0c74464
Type
Standard
Back to HSA Approvals
